The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

PHASE3CompletedINTERVENTIONAL
Enrollment

325

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Lamivudine

DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (22)

10019

Saint Luke's - Roosevelt Hosp Ctr, New York

11554

Nassau County Med Ctr, East Meadow

17033

Milton S Hershey Med Ctr, Hershey

27710

Duke Univ Med Ctr, Durham

28207

Nalle Clinic, Charlotte

30308

AIDS Research Consortium of Atlanta, Atlanta

53202

Wisconsin Community - Based Research Consortium, Milwaukee

60607

Chicago Ctr for Clinical Research, Chicago

70119

Louisiana Cardiovascular Research Ctr, New Orleans

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

75246

Nicholaos Bellos, Dallas

77006

Houston Clinical Research Network, Houston

78751

Central Texas Med Foundation, Austin

90028

Combat Group, Los Angeles

92104

San Diego Community Research Group, San Diego

94103

ViRx Inc, San Francisco

97210

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

02118

Boston City Hosp / FGH-1, Boston

Unknown

Ottawa General Hospital, Ottawa

Toronto Hosp, Toronto

Montreal Gen Hosp, Montreal

00731

Hosp Regional de Ponce - Area Vieja, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY